New Licensing Rules by the Israeli Innovation Authority for Multinational Corporations At the beginning of September, the Israeli Innovation Authority, a division of the Israeli Ministry of Economy and Industry and the successor to the Office of Chief Scientist (“IIA”), issued new rules (“New Rules”) regarding the licensing of know-how developed and obtained by Israeli […]
FBC, in collaboration with US firm Morgan, Lewis & Bockius, represented Perrigo Company in the sale of its active pharmaceutical ingredients business headquartered in Israel for a purchase price of US$110 million. The transaction included the sale of all of the share capital of Perrigo API Ltd. and Perrigo API USA Inc., as well as […]
FBC represented OrbiMed in its $5,325,000 investment in MobileODT Ltd. as part of a Series B Round of approximately $6,825,000 investment, in addition to conversion of SAFEs (“simple agreement for future equity”) in the amount of $3,905,223. The transaction included complex questions with regard to the applicability of the Israeli Securities Law and IP. MobileODT […]
FBC represented QUALCOMM Ventures, in leading a $5 Million investment in Prospera Technologies Ltd., as part of a Series B round of $15 Million. The other investors included Bessemer Venture Partners, Cisco Investments BV and others. QUALCOMM, traded on Nasdaq, is a global leader in research, development, manufacture and marketing of wireless telecommunications products and […]